Immediate Placebo Effect in Parkinson’s Disease – Is the Subjective Relief Accompanied by Objective Improvement?

Publisher： Karger

E-ISSN： 1421-9913|56|4|222-229

ISSN： 0014-3022

Source： European Neurology, Vol.56, Iss.4, 2006-12, pp. : 222-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melatonin and parkinson’s disease

By Mayo Juan   Sainz Rosa   Tan Dun-Xian   Antolín Isaac   Rodríguez Carmen   Reiter Russel  

Endocrine Journal, Vol. 27, Iss. 2, 2005-07 ,pp. : 169-178

Humana Press, Inc

Access to resources Recommend Favorite

Hemihypomimia in Parkinson’s Disease

By  

European Neurology, Vol. 53, Iss. 2, 2005-05 ,pp. : 92-92

Karger

Access to resources Recommend Favorite

Achieving 24-Hour Control of Parkinson’s Disease Symptoms: Use of Objective Measures to Improve Nocturnal Disability

By  

European Neurology, Vol. 46, Iss. 1, 2001-12 ,pp. : 3-10

Karger

Access to resources Recommend Favorite

Prevalence of Parkinson’s Disease in Bulgaria

By  

Neuroepidemiology, Vol. 20, Iss. 3, 2001-08 ,pp. : 212-214

Karger

Access to resources Recommend Favorite

Incidence of Parkinson’s Disease in Bulgaria

By  

Neuroepidemiology, Vol. 34, Iss. 2, 2009-12 ,pp. : 76-82

Karger

Access to resources Recommend Favorite